Task: Answer the multiple choice question.
Question: Which drug exhibits a -71.786% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a: CC(=O)Nc1ccc(S(=O)(=O)NCCCN2CCOCC2)cc1
b: COc1ccc(NC(=O)c2cc3c([nH]c4ccccc43)c(C)n2)cc1
c: CCC(COC(C)=O)Nc1nc2c([nH]1)c(=O)n(C)c(=O)n2C
d: CCC(=O)c1cn(Cc2ccc(C#N)cc2)c2ccccc12
Answer: d. CCC(=O)c1cn(Cc2ccc(C#N)cc2)c2ccccc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)c1cn(Cc2ccc(C#N)cc2)c2ccccc12
CCC(=O)c1cn(Cc2ccc(C#N)cc2)c2ccccc12
4-[(3-propanoylindol-1-yl)methyl]benzonitrile